Enzyme-Linked Immunosorbent Assay Testing Market Size and Demand Forecast 2026–2030
Uncover key drivers, emerging technologies, and competitive movements shaping the enzyme-linked immunosorbent assay testing market from 2026–2035 with trusted insights from The Business Research Company
What market expansion outlook does the Enzyme-Linked Immunosorbent Assay Testing Market show for the 2026–2030 period?
The market size for enzyme-linked immunosorbent assay testing has experienced significant growth over recent years. It is anticipated to expand from $3.04 billion in 2025 to $3.24 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 6.5%. This historical expansion can be primarily attributed to the widespread adoption of ELISA in diagnostic testing, the broadening scope of biomedical research activities, the increasing prevalence of infectious and chronic diseases, a growing reliance on immunoassay techniques, and the availability of standardized testing protocols.
The market for enzyme-linked immunosorbent assay testing is projected to experience robust expansion over the coming years. This market is anticipated to reach a valuation of $4.12 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 6.2%. Factors contributing to this growth during the forecast period include the rising acceptance of automated laboratory processes, an escalating need for diagnostics based on biomarkers, the broadening of ELISA’s utility in oncology and immunology, a heightened emphasis on detecting diseases early, and increased financial commitment to clinical research infrastructure. Key trends anticipated in the forecast period involve the wider implementation of high-throughput ELISA systems, a surge in demand for multiplex immunoassays, the increasing incorporation of automated sample handling, an expanded application of ELISA in clinical research settings, and a reinforced emphasis on the precision and sensitivity of assays.
Access Your Free Sample Report for In-Depth Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=19417&type=smp
What Drivers Are Shaping The Development Of The Enzyme-Linked Immunosorbent Assay Testing Market?
The future expansion of the enzyme-linked immunosorbent assay testing market is anticipated to be driven by the increasing occurrence of infectious disorders. Such disorders are illnesses resulting from pathogenic microorganisms like bacteria, viruses, fungi, or parasites, capable of transmission among people and affecting multiple bodily systems. This rise in infectious disorder cases stems from factors such as increased international travel and the emergence of antimicrobial resistance, making infection management more challenging. Enzyme-linked immunosorbent assay (ELISA) testing offers utility for infectious disorders by precisely identifying and measuring particular antigens or antibodies linked to the infection, thereby assisting in diagnosis, tracking disease progression, and assessing treatment efficacy. As an illustration, the World Health Organization, an intergovernmental public health body headquartered in Switzerland, reported in February 2024 that the European Region saw 58114 measles cases in 2023, a significant increase from 941 cases in 2022, highlighting the highly contagious nature of this viral disease. Consequently, the escalating occurrence of infectious illnesses is fueling the expansion of the enzyme-linked immunosorbent assay testing market.
What Segment Types Are Examined In The Enzyme-Linked Immunosorbent Assay Testing Market?
The enzyme-linked immunosorbent assay testing market covered in this report is segmented –
1) By Type: Direct Enzyme-Linked Immunosorbent Assay (ELISA), Sandwich Enzyme-Linked Immunosorbent Assay (ELISA), Indirect Enzyme-Linked Immunosorbent Assay (ELISA), Multiple And Portable Enzyme-Linked Immunosorbent Assay (ELISA), Competitive Enzyme-Linked Immunosorbent Assay (ELISA)
2) By Application: Immunology, Inflammation, Infectious Diseases, Cancer, Protein Quantitation, Other Applications
3) By End-User: Hospitals And Diagnostic Centers, Research Laboratories, Other End-Users
Subsegments:
1) By Direct Enzyme-Linked Immunosorbent Assay (ELISA): Single-Step Direct ELISA, Competitive Direct ELISA, Quantitative Direct ELISA, Qualitative Direct ELISA
2) By Sandwich Enzyme-Linked Immunosorbent Assay (ELISA): Two-Step Sandwich ELISA, One-Step Sandwich ELISA, Quantitative Sandwich ELISA, Qualitative Sandwich ELISA
3) By Indirect Enzyme-Linked Immunosorbent Assay (ELISA): Standard Indirect ELISA, Competitive Indirect ELISA, Quantitative Indirect ELISA, Qualitative Indirect ELISA
4) By Multiple And Portable Enzyme-Linked Immunosorbent Assay (ELISA): Multiplex ELISA (Multi-Analyte ELISA), Portable / Point-of-Care (POC) ELISA, Microfluidic-Based ELISA, Quantitative Portable ELISA, Qualitative Portable ELISA
5) By Competitive Enzyme-Linked Immunosorbent Assay (ELISA): Direct Competitive ELISA, Indirect Competitive ELISA, Quantitative Competitive ELISA, Qualitative Competitive ELISA
What Upcoming Trends Are Likely To Define The Future Path Of The Enzyme-Linked Immunosorbent Assay Testing Market?
Leading firms within the enzyme-linked immunosorbent assay testing market are concentrating on expanding their product portfolios via innovations like advanced enzyme-linked immunosorbent assay (ELISA) kits, aiming to boost diagnostic precision and address various research and clinical requirements. These novel Enzyme-Linked Immunosorbent Assay (ELISA) kits represent enhanced iterations of ELISA tests, providing superior accuracy, heightened sensitivity, and greater ease of use for the identification and measurement of biomarkers. As an illustration, Charles River Laboratories, a pharmaceutical company based in the US, launched a new enzyme-linked immunosorbent assay (ELISA) kit in February 2023, designed to detect and quantify residual host cell proteins (HCP) present in CHO-based biotherapeutics. This innovative kit employs avian immunoglobulin Y (IgY) antibodies derived from specific pathogen-free (SPF) chicken eggs, thereby offering improved sensitivity and specificity, evidenced by detection limits reaching as low as 0.1 ng/mL and an antibody coverage of 90%. The introduction of this product is intended to elevate quality control standards in biopharmaceutical development, guaranteeing the safety and effectiveness of emerging therapies, while also enabling clients to utilize it flexibly, either autonomously or with assistance from Charles River’s specialists.
Who Are The Core Companies Influencing Trends In The Enzyme-Linked Immunosorbent Assay Testing Market?
Major companies operating in the enzyme-linked immunosorbent assay testing market are Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, Siemens Healthineers, Becton Dickinson and Company, Agilent Technologies Inc., PerkinElmer Inc., Bio-Rad Laboratories Inc., Tecan Group Ltd., GenScript Biotech Corporation, Promega Corporation, Abcam plc, R&D Systems Inc, Sino Biological Inc., OriGene Technologies Inc., RayBiotech Inc., Santa Cruz Biotechnology Inc., AnaSpec Inc., Biomatik, Arigo Biolaboratories Corp., MyBioSource Inc., Boster Biological Technology, Eagle Biosciences Inc., Enzo Life Sciences Inc., StressMarq Biosciences Inc., XpressBio
Access The Complete Report For Deeper Market Insights:
Which Geographic Areas Are Emerging As Strong Markets For The Enzyme-Linked Immunosorbent Assay Testing Market?
North America was the largest region in the enzyme-linked immunosorbent assay testing market in 2025. The regions covered in the enzyme-linked immunosorbent assay testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request Your Customized Enzyme-Linked Immunosorbent Assay Testing Market Research Report for Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=19417&type=smp
Browse Through More Reports Similar to the Global Enzyme-Linked Immunosorbent Assay Testing Market 2026, By The Business Research Company
Bioanalytical Testing Services Market Report 2026
Noise Vibration Harshness Testing Market Report 2026
Cannabis Testing Market Report 2026
https://www.thebusinessresearchcompany.com/report/cannabis-testing-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
